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G A D 6 5 IS RECOGNIZED BY T-CELLS, BUT NOT BY 
ANTIBODIES FROM NOD-MICE 
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(Received September 30, 1993; in final form January 4, 1994) 
Since the 64kDa-protein glutamic acid decarboxylase (GAD) is one of the major autoantigens in T-cell 
mediated Type 1 diabetes, its relevance as a T-cell antigen needs to be clarified. After isolation of 
splenic T-cells from non-obese diabetic (NOD) mice, a useful model for human Type 1 diabetes, we 
found that these T-cells proliferate spontaneously when incubated with human G A D 6 5 , but only 
marginally after incubation with G A D 6 7 , both recombinated in the baculovirus system. No effect was 
observed with non-diabetic N O D mice or with T-cells from H-2 identical N O N - N O D - H - 2 8 7 control 
mice. It has been published previously that N O D mice develop autoantibodies against a 64kDa 
protein detected with mouse beta cells. In immunoprecipitation experiments with sera from the same 
N O D mice and 3 5S-methionine-labelled G A D , no autoantibody binding could be detected. We 
conclude firstly that G A D 6 5 is an important T-cell antigen which is relevant early in the development 
of Type 1 diabetes and secondly that there is an antigenic epitope in the human G A D 6 5 molecule 
recognized by N O D T-cells, but not by N O D autoantibodies precipitating conformational epitopes. 
Our results therefore provide further evidence that G A D 6 5 is a T-cell antigen in N O D mice, being 
possibly also involved in very early processes leading to the development of human Type 1 diabetes. 
K E Y W O R D S : Type 1 (insulin-dependent) diabetes mellitus, non obese diabetic (NOD) mouse, 
autoimmunity, T-cells, glutamic acid decarboxylase (GAD) 
INTRODUCTION 
Type 1 (insulin-dependent) Diabetes mellitus (IDDM) 
is an autoimmune disease leading to the destruction of 
insulin producing beta cells in the pancreatic islets of 
Langerhans [1]. T-cells are crucially involved in the 
process of beta cell destruction [2]. However, except 
from the 38kDa protein, no diabetes specific T-cell 
antigen has been identified [3]. A number of antibod-
ies specific for islet cell proteins have been detected in 
the sera from type 1 diabetic patients and are used as 
markers for the evaluation of risk factors of the dis-
ease. One of the most reliable and earliest markers in 
Type 1 diabetes are autoantibodies directed against 
the 64kDa antigen, which has been identified as glu-
tamic acid decarboxylase (GAD) [4]. Immunoprecipi-
tating antibodies to GAD have been shown to be 
present in 70% of newly diagnosed type 1 diabetic 
patients and in 87% of their islet cell antibody (ICA)-
positive first degree relatives [5] as well as in 56% of 
patients with Stiff Man Syndrom (SMS) [6,7]. GAD 
catalyzes the convertion of glutamic acid into the 
neurotransmitter γ-amino butyric acid (GABA) and is 
Correspondence to: Prof. Werner A. Scherbaum, M D , Depart­
ment of Endocrinology, Johannisallee 32, 04103 Leipzig, F R G 
found in two isoforms, GAD 6 5 and GAD 6 7 , both in 
neurons and in synaptic like vesicles in rodent insulin 
producing beta cells [8]. 
Since it is not proved that autoantibodies against 
beta cell antigens have any deleterious effect in the 
pathogenesis of Type 1 diabetes, several attempts have 
been made to elucidate the role of GAD as a T-cell 
autoantigen. T-cells in the peripheral blood of diabetic 
patients and their first degree relatives have been 
shown to recognize GAD 6 5 recombinated in E. coli [9] 
or GAD 6 7 [10]. T-cell lines specific for Escherichia coli 
GAD 6 5 have been isolated from BB-rats, an animal 
model of Type 1 diabetes [11]. The non-obese diabetic 
(NOD) mouse, another well known animal model for 
human Type 1 diabetes mellitus, resembles the situa­
tion in humans in many clinical, immunological and 
immunogenetical aspects [12,13]. Antibodies in NOD 
mice directed against a 64kDa protein in mouse islets 
have been reported several years ago [14], whereas 
antisera to GAD 6 5 /GAD 6 7 raised in different species 
including sheep, rabbit and mouse could only detect 
small amounts of GAD 6 7 , but not GAD 6 5 in mouse 
islets by Western blot analysis [15]. 
In this study we examined the ability of GAD 6 5 and 
GAD 6 7 to stimulate T-cells isolated from spleens of 
NOD mice of different age and metabolic state of 
disease. As a control we used non-diabetic MHC-
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matched NON-NOD-H-2ß7 mice. Human recombi-
nated GAD 6 5 and GAD 6 7 were used as antigens. To 
evaluate the antibody response to both antigens, we 
performed immunoprecipitation experiments with the 
sera from NOD mice. 
MATERIAL AND METHODS 
Mice 
Female NOD mice were obtained from Bommice, 
Bomholtgard, Rye, Denmark and kept under germfree 
conditions. The incidence of diabetes in this colony 
was 80% by 16-18 weeks of age in females and 20-
30% in male. Control non-diabetic NON-NOD-H-2g7 
mice were obtained from L. Herberg, Diabetes For-
schungsinstitut, Düsseldorf, Germany. In our experi-
ments, NOD and control mice were of the same age. 
The metabolic status was determined by blood glucose 
measurement. Blood was drawn from the portal vein 
and blood glucose levels were measured in an Eppen-
dorf APC 40/50. Mice with blood glucose values 
> 13 mmol/1 were considered to be diabetic. 
Antigen expression and preparation 
Purified human GAD 6 5 and GAD 6 7 were expressed in 
Spodoptera frugiperda (SP9) cells as described recently 
[16]. Briefly, human GAD 6 5 and GAD 6 7 cDNA clones 
were constructed by inserting full length human 
GAD 6 5 and GAD 6 7 cDNAs into the baculovirus vec-
tor pVL1393 (Invitrogen). After infection, Sf9 cells 
were cultured in SF900 medium (Gibco, Heidelberg) 
supplemented with 0.04% fetal calf serum. Cells were 
harvested 48h later and homogenized in 20 mM potas-
sium phosphate, pH 7,0, 2 mM EDTA, 2 mM PMSF, 
5 μ/ml Leupeptin, 1 mM AET, 0,2 mM PLP (buffer 
A). Homogenates of cells infected with the GAD re­
combinants, or cells infected with the vector lacking 
the GAD insert were used as antigens in T-cell prolif­
eration experiment or for immunoprecipitation. 
Determination of GAD enzyme activity 
Enzymatic activity of GAD was determined using a 
modification of the method described by Miller et al. 
[17]. Aliqouts of the SF9 cell homogenates were di­
luted in 50 mM potassium phosphate buffer, pH 7.0 
with 1 mM EDTA, 1 mM AET, 0.2 mM PLP to a final 
volume of 200 μΐ. L-glutamic acid was added to a final 
concentration of 1 mM and L-[1-1 4C] glutamic acid 
was added to a final radioactivity of 500 μο/ηιπιοΐ. 
After adding the reaction mixture into glass tubes, a 
filter paper soaked with 50 μΐ I M hyamin hydroxide 
was placed into the tubes. The tubes were closed and 
after an incubation of 1 h at 37°C, the reaction was 
stopped by injecting 1 ml 5N sulphuric acid followed 
by an equilibration period of 1 h to allow complete 
adsorption of release 1 4 C0 2 . The 1 4 C0 2 trapped to the 
filter paper was measured by liquid scintillation count­
ing and GAD enzyme activity was expressed in 
Units/mg protein. 1 Unit [U] was defined as the for­
mation of 1 μιτιοί C0 2/min under standard assay con­
ditions. 
Isolation of T-cells and proliferation assays 
For each experiment 3 female NOD mice or 3 female 
NON.NOD-H-2g7 mice of the same age were killed. 
The animals were non-fasting. Presence of insulitis 
was determined by hematoxylin/eosin staining of 
kryo-sections of the pancreata isolated immediately 
after killing. 
Isolation of T-cells was performed as described [18]. 
Briefly, spleens were removed aseptically and a ho­
mogenous cell suspension comprising spleen cells from 
all three animals in complete RPMI-640 medium 
(RPMI-1640, supplemented with 10% fetal calf serum, 
10 units/ml penicillin/streptomycin, 200 mmol/1 
L-glutamine and 5x10" 5 mol/1 ß-mercaptoethanol) 
was prepared. Mononuclear splenic cells were sepa-
rated by density gradient centrifugation on Ficoll-400 
cushions (Lymphoprep, Boehringer Mannheim, Man-
nheim FRG). The interface containing the mononu-
clear cells was recovered, washed and passed over 
nylon wool columns to obtain purified T-cells. Purity 
of the T-cell preparations was > 90% as analyzed by 
anti-CD3-antibody labelling and subsequent Fluores-
cence activated cell sorter analysis. Triplicate assays 
were carried out by culturing 3 χ 104 purified T-cells in 
a total volume of 200 μΐ of complete RPMI-640 in 
96-well microtitre plates in the presence of 3 χ 105 
irradiated (3000 rad) syngeneic spleen cells as antigen 
presenting cells (APC). For proliferation assays, the 
antigenic fractions were used in concentrations of 10, 
2, 0,5 and 0 ,^g/ml to determine their respective 
optimal concentration for stimulation of the T-cells. In 
each case concanavalin A (1 μg/ml) was used as a 
positive control for T-cell proliferation. The basal 
stimulatory activity was ascertained in the presence of 
complete cell culture medium without antigen. The 
cultures were incubated for 72-86 h, then pulsed with 
1 μα per well 3H-methyl-thymidine (3H-TdR) (Amer-
sham Buchler, Braunschweig, FRG) and harvested 
20 h later. The incorporated radioactivity was deter­
mined using a Betaplate scintillation counter. Prolifer­
ation was expressed as stimulation index (SI): lympho­
cyte DNA synthesis/3H-TdR incorporation/counts per 
min (cpm) in the presence of antigen over cpm in the 
absence of antigen. 
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Immunoprecipitation assay 
Immunoprecipitation was performed with sera from 
NOD and control mice. As a positive control we used 
the murine monoclonal antibody GAD 1 recognizing 
GAD 6 5 and the polyclonal rabbit antibody K2 shown 
to recognize both GAD 6 5 and GAD 6 7 [8]. The assays 
were performed following a modification of the 
method published by Seissler et al [19]. 
Infected Sf9 cells were cultured in Grace's medium 
(Gibco). After 36 h, 3 5S- methionine (200 \iC\l5 χ 106 
cells) were added. 6 h later the cells were harvested 
and homogenized in buffer A. Homogenates were cen-
trifugated at 33,000 g for 30 min to separate the solu­
ble cytosolic fraction (CF). The cell pellets were resus-
pended in 20 mM potassium phosphate, 50 mM NaCl 
pH 7,2, 2 mM EDTA, 2 mM PMSF, 1% Trasylol, 1% 
Triton χ 100 for 2 h at 4°C followed by centrifugation 
at 33,000 g for 30 min to obtain the membrane frac­
tion (MF) in the supernatant. MF was incubated with 
a pool of normal human serum (25μ1/100μ1 lysate) 
for 6 h and then preabsorbed with protein A sepharose 
(Pharmacia, Freiburg). 100 μΐ of the precleared ex­
tracts were precipitated with 25 μΐ Type 1 diabetes or 
NOD mouse serum, followed by adsorption of the 
immunocomplexes by a mixture of protein A and 
protein G sepharose. After extensive washing the 
bound proteins were eluted with 65 mM Tris/HCl pH 
6,8, 2% SDS, 5% ß-mercaptoethanol and analysed by 
fluorography. 
Statistical analysis 
Data of T-cell assays are shown as means + / - stan-
dard deviation (SD) from at least three identically 
performed experiments. The results were assessed by 
one-way analysis of variance. Differences with 
p-values less than 0.01 were considered to be signifi-
cant. 
RESULTS 
Prior to performance of the proliferation experiments, 
enzymatic activity of the cell lysates was determined. 
For GAD 6 5 it was 55 mU/mg and for GAD 6 7 69 mU/ 
mg. Splenic T-cells from NOD mice of 8-10, 17-20 
and 28 weeks of age were incubated with different 
concentrations of GAD 6 5 or GAD 6 7 . As shown in 
Figure 7, both GAD 6 5 and GAD 6 7 were recognized by 
the NOD mouse Τ cells in a dose dependent manner 
with an incorporated radioactivity of 0,8 - 1,5 χ 10" 3 
counts per minute (cpm) compared to background 
stimulation index (SI) 
0,1 0,5 2 10 
antigen concentration [gg/ml] 
Fig. 1 Spontaneous proliferation of splenic T-cells from 20 weeks old, diabetic N O D mice after a 72 h-incubation with 0,1, 0,5, 2 or 
10μ§/πι1 G A D 6 5 ( • ) or G A D 6 7 (^ ) , compared to proliferation of splenic T-cells from non-diabetic, age and H-2-matched 
N O N - N O D control mice after incubation with G A D 6 5 (M) or G A D 6 7 (ffl). Proliferation is shown as stimulation index (SI) with 
incorporation values of 800-1500 cpm in presence and 50-100 cpm in absence of antigen. Positive control values obtained after 
incubation of the T-cells with Con A were between 3000 and 5000 cpm. T-cells from NOD-mice respond in a dose dependent manner 
both to G A D 6 5 and G A D 6 7 , whereas proliferation of T-cells from control mice is considerably reduced. 
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cpm levels of 0,05-0,1 χ 10~3 cpm. Table 1 shows 
that the proliferation of the T-cells obtained from 
NOD mice at every age class and metabolic state 
studied were increased after stimulation with GAD 6 5 . 
Proliferative responses towards GAD 6 7 could also be 
observed, but were considerably reduced when the 
corresponding SI-values in each of the age groups were 
compared. This effect was also observed with T-cells 
from 8-10 weeks old NOD mice, which had not yet 
developed overt diabetes, but had mononuclear cells 
infiltrating the islets. T-cells from these mice showed 
marginal responses after incubation with GAD 6 7 . 
When we used T-cells from non-diabetic, MHC-
matched NON-NOD-H-2g7 control mice, only a small 
effect could be seen either after incubation with GAD 6 7 
or with GAD 6 5 {Table 1). By using homogenates from 
SF9 cells not expressing GAD as an antigen to test 
unspecific T-cell response to SF9-cellular proteins, no 
significant proliferation of the T-cells both from NOD 
and NON-NOD mice was detected {Table 1). T-cells 
from non diabetic NOD mice which did not show any 
histological signs of islet infiltration did not respond to 
G A D 6 5 or GAD 6 7 (data not shown). 
In immunoprecipitation experimens, sera from the 
same mice which have been used for T-cell isolation in 
the above described experiments were tested. Immu­
noprecipitation studies were performed with extracts 
from GAD 6 5 expressing SF9 cells which had been 
metabolically labelled by 35S-methionine incorpora­
tion. As a control for the suitability of the immunopre­
cipitation method for mouse sera, we used the mono­
clonal mouse antibody GAD 1 which recognizes 
G A D 6 5 and the polyclonal rabbit antibody K2 recog­
nizing mainly GAD 6 7 . As shown in Figure 2, the mon­
oclonal antibody GAD 1 and the polyclonal antibody 
K2 could precipitate GAD 6 5 or GAD 6 7 from the SF9 
cell extract. None of the NOD mouse or NON-NOD 
mouse sera gave a positive binding signal. 
DISCUSSION 
With this study evidence is provided that human 
GAD 6 5 contains an antigenic epitope or antigenic 
epitopes for NOD T-cells, different from the epitope(s) 
recognized by NOD autoantibodies. In a previous 
study, reactivity of peripheral blood T-cells isolated 
from human type 1 diabetic patients towards GAD 
expressed in E.coli was reported [9]. When recombi­
nated GAD 6 5 from E.coli or E.coli extract without 
GAD 6 5 was used, T-cells isolated from NOD mice and 
from non-diabetogenic control mice proliferated 
equally strong (data not shown). This might be due to 
E.coli contaminating proteins which stimulated the 
T-cells in an unspecific manner. When we used human 
GAD 6 5 and GAD 6 7 recombinated in the baculovirus 
system and expressed in SF9 cells, the T-cell prolifer­
ation signals in response to GAD 6 5 were increased 
compared to GAD 6 7 ; background levels of prolifera­
tion to SF9 cell extract were significantly lower. These 
results are remarkable since in a recent report only 
GAD 6 7 was immunologically detectable on mouse islet 
cells [15]. It might yet be possible that the amount of 
GAD 6 5 molecules on mouse islets is too small to be 
detected in immunoassays, but sufficient to prime 
specific T-cells in vivo. The human form of GAD 6 5 
apparently provides an epitope which is immunologi­
cally effective for stimulation of NOD T-cells. 
Table 1 Proliferation of T-cells from N O D - and NON-NOD-mice after in vitro stimulation with human recombinated G A D 6 5 or 
G A D 6 7 . Extract of SF9 cells not expressing G A D was used as a negative tissue control. Proliferation was measured after 
3H-thymidine incorporation with background levels of T-cell proliferation of 50-100 counts per minute (cpm), and is expressed as 
stimulation index (SI) + / - standard deviation (SD) from at least three identically performed experiments. The table shows 
significantly higher proliferation of NOD-mouse T-cells after stimulation with G A D 6 5 compared to the respective results obtained 
with T-cells from non-diabetic, H-2 compatible NON-NOD-control mice of the same age group ('*' for G A D 6 5 and '**' for G A D 6 7 ) 
and compared to the respective T-cell proliferation after incubation with SF9 cell homogenate ('#'). 
proliferation of T-cells [SI] 
age of mice diabetic3 
antigen [weeks] yes/no N O D N O N - N O D 
G A D 6 5 8-10 no 1 0 . 3 ± 2 . 0 * # 0.9 ± 0 . 2 * 
17-20 yes 1 1 . 0 ± 0 . 7 * # 1 . 9 ± 1 . 0 * 
28-30 yes 6 . 7 ± 2 . 1 2 . 7 ± 1 . 2 
G A D 6 7 8-10 no 4.6 ± 1 . 4 * * 1.2 ± 0 . 3 * * 
17-20 yes 6.1 ± 2 . 9 2 . 0 ± 0 . 3 
28-30 yes 1 . 8 ± 1 . 0 1 . 8 ± 1 . 3 
SF9- 8-10 no 2 . 0 ± 1 . 4 # 3 . 2 ± 0 . 8 
extract 17-20 yes 1 . 7 ± 0 . 3 # 2 . 5 ± 0 . 6 
28-30 yes 0.2 3 . 4 ± 0 . 5 
afor NOD-mice 
* - p < 0.001 
* * - / ? < 0.01 
# - p < 0.001 
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Fig. 2 Autoradiography after immunoprecipitation of human 
recombinated 35S-methionine-labelled G A D 6 5 (lane 1-5) and 
G A D 6 7 (lane 6-10). As positive controls, the mouse monoclonal 
antibody G A D 1 precipitating G A D 6 5 (lane 1) and the rabbit 
polyclonal antibody K2 precipitating G A D 6 7 (lane 6) were used. 
The molecular weights ( M w ) are indicated. With undiluted sera 
from N O D mice aged 8-10 weeks (lanes 2 and 7), 17-20 weeks 
(lanes 3 and 8) or 28-30 weeks (lanes 4 and 9) or with undiluted 
NON-NOD mouse sera (lanes 5 and 10) no binding signal was 
obvious. 
In our study, non-diabetic, H-2 identical control 
mice which did not show any signs of insulitis, did not 
respond to either form of GAD. This could implicate 
an MHC-independent mechanism of GAD 6 5 recogni­
tion by the T-cells from NOD mice, but further block­
ing experiments with anti-H2 antibodies will be neces­
sary to prove the influence of the NOD-mouse specific 
H-2 complex in the recognition of diabetes specific 
antigens. In a previous study we reported the presence 
of T-cell autoantigens in very young NOD mice [18]. 
Here we show that GAD 6 5 is one of the autoantigens 
eliciting T-cell response towards the pancreatic islets, 
which is relevant in the early development of insulitis 
and diabetes. 
When immunoprecipitation experiments with met-
abolically labelled GAD 6 5 and GAD 6 7 were per­
formed, no binding signal with undiluted NOD-mouse 
sera was obtained in contrast to positive binding by 
the control antibodies GAD 1 and K2. Nevertheless, 
the assay itself is suitable for detection of both human 
and mouse antibodies: In one of our previous studies 
we have already been able to show a positive binding 
signal with ICA + sera from human type 1 diabetic 
patients and GAD 6 5 recombinated in Baculovirus by 
using this immunoprecipitation assay [5] and in this 
study the murine monoclonal antibody GAD1 was 
able to precipitate GAD 6 5 , which implicates that the 
missing GAD 6 5 or GAD 6 7 binding signal by using 
NOD mouse sera is not due to technical problems. 
The presence of autoantibodies towards a 64kDa 
protein in the serum of NOD mice was reported 
several years ago by Atkinson et al. [14], although 
evidence is still lacking that this 65kDa-protein equals 
GAD 6 5 ; immunoprecipitation studies performed with 
tryptic islet fragments indicate the existance of another 
64kDa-protein in islet beta cells [20]. Another group 
recently reported enzymatic GAD activity in mouse 
islets, but also noted species specific differences in the 
expression of immunologically relevant forms of the 
antigen [15]. 
T-cells recognize proteogenic peptides comprising a 
small number of amino acids processed by antigen 
presenting cells and presented in conjunction with 
molecules of the major histocompatibility complex 
(MHC) [21,22,23]. In contrast, antibodies bind three 
dimensional structures of protein molecules [24]. In 
epitope studies with influenza virus haemagglutinin 
(HA) it has been demonstrated that amino acid 
changes in the molecule affect the conformational 
structure and the antibody binding, whereas cell sur­
face localization and response of cytotoxic T-cells was 
not impaired [25]. It is therefore possible that amino 
acid sequences within a protein molecule serve as a 
T-cell antigen, but are cryptic to B-cell recognition by 
conformational structures. This might be the case with 
GAD 6 5 , since it is shown here that in NOD mice, 
T-cells are able to recognize GAD as an antigen 
whereas no antibody response was detected. 
Our results contribute to the examination of the role 
of autoreactive T-cells in the pathogenesis of Type 1 
diabetes and demonstrate the difference in immuno­
logical recognition of GAD as a beta cell antigen. We 
would suggest that the presentation of the T-cell 
epitope reacting with GAD-specific T-cells is one of 
the factors triggering beta cell destruction. The Β cell 
response seems to be secondary to the T-cell response 
to GAD and independent from this process. Further 
investigations will be necessary to affirmate the trigger­
ing effect of GAD reactive T-cells in the NOD mouse 
or in human Type 1 diabetes. 
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